What is the differential diagnosis for a 67-year-old man with a chronic cough who is not taking an angiotensin-converting enzyme inhibitor and has no infectious symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnosis for Chronic Cough in a 67-Year-Old Male

In this 67-year-old man with chronic cough, not on an ACE inhibitor and without infectious symptoms, focus your diagnostic workup on the "big three" causes: Upper Airway Cough Syndrome (UACS), asthma (including cough-variant asthma), and gastroesophageal reflux disease (GERD)—which together account for 92-100% of chronic cough cases in nonsmokers with normal chest X-rays 1.

Primary Differential Diagnoses

The Big Three (Account for >90% of cases)

  1. Upper Airway Cough Syndrome (UACS) - formerly called post-nasal drip syndrome

    • Can present as "silent" with cough as the only symptom
    • Due to various rhinosinus conditions
    • Most common single cause in multiple international studies 1
  2. Asthma (including cough-variant asthma)

    • May present with cough alone, without wheezing or dyspnea
    • "Silent" presentation is common
    • Requires spirometry and bronchoprovocation testing for diagnosis 1
  3. Gastroesophageal Reflux Disease (GERD)

    • Can be "silent" without typical heartburn or regurgitation
    • Note: Acid suppression alone is no longer recommended for treatment 2
    • Often coexists with other causes

Important Additional Considerations

  1. Nonasthmatic Eosinophilic Bronchitis (NAEB)

    • Prevalence ranges from 13-33% in international studies 1
    • Characterized by eosinophilic airway infiltration with normal spirometry
    • Diagnosed via induced sputum eosinophil count
    • Responds predictably to inhaled corticosteroids 1
  2. Chronic Bronchitis/COPD

    • Particularly relevant given patient's age (67 years)
    • Must assess smoking history (current or former)
    • Requires spirometry for diagnosis 3, 4

Critical Red Flags to Exclude First

Before pursuing the common causes, immediately evaluate for these warning signs 2:

  • Hemoptysis
  • Smoker >45 years with new or changed cough (or coexisting voice disturbance)
  • Adults 55-80 years with 30 pack-year history (current smoker or quit within 15 years) - this patient's age makes lung cancer screening criteria relevant
  • Prominent dyspnea (especially at rest or nocturnal)
  • Hoarseness
  • Systemic symptoms: fever, weight loss
  • Peripheral edema with weight gain
  • Dysphagia
  • Recurrent pneumonia

Initial Diagnostic Approach

Step 1: Essential History Elements

  • Smoking status (current, former, pack-years)
  • Medication review - confirm no ACE inhibitor use; also check for sitagliptin 2
  • Environmental/occupational exposures 2
  • Duration of cough (chronic = >8 weeks) 2
  • Associated symptoms: post-nasal drip sensation, heartburn, wheezing, dyspnea
  • Past medical history: COPD, asthma, prior malignancy, tuberculosis, AIDS 1

Step 2: Initial Testing

  • Chest X-ray - mandatory to exclude masses, infiltrates, bronchiectasis 2, 4
  • Spirometry with bronchodilator response 3, 4
  • Exhaled nitric oxide (FeNO) - if available, helps identify eosinophilic inflammation 3
  • Blood eosinophil count 3

Step 3: Empiric Treatment Trials (4-6 weeks each)

If initial testing is normal or near-normal, proceed with empiric treatment for the most likely causes 2, 3:

  1. Trial for UACS: First-generation antihistamine/decongestant combination or intranasal corticosteroid
  2. Trial for asthma: Inhaled corticosteroid ± bronchodilator
  3. Trial for GERD: Proton pump inhibitor PLUS lifestyle modifications (note: PPI alone is insufficient) 2

Critical caveat: These conditions frequently coexist—up to 62% of patients have multiple simultaneous causes 1. If partial response occurs, continue that treatment and add therapy for the next most likely diagnosis.

Less Common but Important Causes

  • Bronchiectasis - consider if productive cough with purulent sputum
  • Interstitial lung disease - if abnormal chest imaging or restrictive pattern on spirometry
  • Endobronchial lesions - tumors, sarcoidosis, tuberculosis
  • Congestive heart failure - if peripheral edema present
  • Post-infectious cough - though often resolves during workup; consider pertussis in epidemic settings 1
  • Medication-induced - sitagliptin (DPP-4 inhibitor) in addition to ACE inhibitors 2

Common Pitfalls to Avoid

  1. Don't rely on cough characteristics: The timing, character, or presence/absence of sputum production has NO diagnostic value 1

  2. Don't assume single etiology: Multiple causes coexist in the majority of cases—if one treatment partially helps, add therapy for other likely causes rather than abandoning the first 1

  3. Don't overlook "silent" presentations: UACS, asthma, and GERD commonly present with cough as the ONLY symptom 1

  4. Don't order extensive testing prematurely: If no red flags and normal chest X-ray, empiric treatment trials are more cost-effective than extensive diagnostic workup 2, 3

  5. Don't forget NAEB: This diagnosis requires induced sputum analysis but is easily treated with inhaled corticosteroids—consider early in the workup 1

When to Refer or Escalate

  • Presence of any red flags - immediate evaluation for malignancy, tuberculosis, or other serious pathology 2
  • Failure to respond after 4-6 weeks of appropriate empiric therapy 2
  • Refractory or unexplained chronic cough - refer to specialized cough clinic 2, 3
  • Abnormal chest imaging requiring CT or bronchoscopy 4

Follow-Up Strategy

Patients should be routinely followed within 4-6 weeks after initial evaluation to assess treatment response and adjust therapy 2. Use validated cough severity tools to objectively measure outcomes 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.